Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|4|438-464

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.4, 2015-02, pp. : 438-464

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glutamate Carboxypeptidase II: An Overview of Structural Studies and Their Importance for Structure-Based Drug Design and Deciphering the Reaction Mechanism of the Enzyme

By  

Current Medicinal Chemistry, Vol. 19, Iss. 9, 2012-03 ,pp. : 1300-1309

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Structure Prediction in Structure Based Drug Design

By  

Current Medicinal Chemistry, Vol. 11, Iss. 5, 2004-03 ,pp. : 551-558

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-toxicity relationships for selected halogenated aliphatic chemicals

By Whiteley M.S.   Galland R.B.   Akers K.S.   Sinks G.D.   Schultz T.W.  

Environmental Toxicology and Pharmacology, Vol. 7, Iss. 1, 1999-03 ,pp. : 33-39

Elsevier

Access to resources Recommend Favorite

The application of quantum mechanics in structure-based drug design

By Mucs Daniel   Bryce Richard A  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 3, 2013-03 ,pp. : 263-276

Informa Healthcare

Access to resources Recommend Favorite

Protein Structure Network-based Drug Design

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 16, 2016-11 ,pp. : 1330-1343

Bentham Science Publishers

Access to resources Recommend Favorite